# Monte Rosa Therapeutics, Inc.: filings

GLUE · Nasdaq · CIK 1826457 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/glue.md) · [Financials](/companies/glue/financials.md) · [Filings](/companies/glue/filings.md) · [Insiders](/companies/glue/insiders.md)

## Reports and events: 93 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 135, 8-K 52, 3 36, 144 32, 10-Q 16, SC 13G/A 16, SCHEDULE 13G/A 16, CORRESP 8, SC 13G 7, UPLOAD 7, DEFA14A 6, S-8 6, SC 13D/A 6, SCHEDULE 13G 6, 10-K 5, 424B5 5, DEF 14A 5, ARS 4, SCHEDULE 13D/A 4, EFFECT 3, 144/A 2, D 2, DRS/A 2, S-1/A 2, S-3 2, SC 13D 2, SEC STAFF LETTER 2, 424B4 1, 8-A12B 1, CERT 1, DRS 1, DRSLTR 1, PRE 14A 1, S-1 1, S-1MEF 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 11:38 ET | [8-K](/filings/0001193125-26-409833.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-409833 |
| 2026-09-08 | 11:02 ET | [8-K](/filings/0001193125-26-384360.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-384360 |
| 2026-08-06 | 11:09 ET | [10-Q](/filings/0001193125-26-336711.md) | Quarterly report, period 2026-06-30 | 0001193125-26-336711 |
| 2026-08-06 | 11:04 ET | [8-K](/filings/0001193125-26-336681.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336681 |
| 2026-07-06 | 21:51 ET | [SCHEDULE 13D/A](/filings/0001072613-26-000558.md) | Ownership report, active investor, amended | 0001072613-26-000558 |
| 2026-06-11 | 20:01 ET | [8-K](/filings/0001193125-26-267465.md) | 5.07 Shareholder vote results | 0001193125-26-267465 |
| 2026-05-07 | 11:30 ET | [10-Q](/filings/0001193125-26-210358.md) | Quarterly report, period 2026-03-31 | 0001193125-26-210358 |
| 2026-05-07 | 11:05 ET | [8-K](/filings/0001193125-26-210298.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210298 |
| 2026-04-29 | 20:01 ET | [DEF 14A](/filings/0001193125-26-191439.md) | Proxy statement, period 2026-04-29 | 0001193125-26-191439 |
| 2026-03-19 | 20:05 ET | [SCHEDULE 13D/A](/filings/0001072613-26-000294.md) | Ownership report, active investor, amended | 0001072613-26-000294 |
| 2026-03-17 | 11:14 ET | [10-K](/filings/0001193125-26-109360.md) | Annual report, period 2025-12-31 | 0001193125-26-109360 |
| 2026-03-17 | 11:04 ET | [8-K](/filings/0001193125-26-109353.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-109353 |
| 2026-02-10 | 21:01 ET | [8-K](/filings/0001193125-26-044616.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-044616 |
| 2026-01-09 | 21:32 ET | [8-K](/filings/0001193125-26-009005.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009005 |
| 2026-01-09 | 21:19 ET | [SCHEDULE 13D/A](/filings/0001193125-26-008951.md) | Ownership report, active investor, amended | 0001193125-26-008951 |
| 2026-01-07 | 21:17 ET | [8-K](/filings/0001193125-26-006341.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-006341 |
| 2026-01-07 | 12:06 ET | [8-K](/filings/0001193125-26-005420.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-005420 |
| 2025-12-16 | 12:30 ET | [8-K](/filings/0001193125-25-319981.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-319981 |
| 2025-11-12 | 21:13 ET | [SCHEDULE 13D/A](/filings/0001193125-25-277603.md) | Ownership report, active investor, amended | 0001193125-25-277603 |
| 2025-11-06 | 12:05 ET | [10-Q](/filings/0001193125-25-268045.md) | Quarterly report, period 2025-09-30 | 0001193125-25-268045 |
| 2025-11-06 | 12:03 ET | [8-K](/filings/0001193125-25-268042.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-268042 |
| 2025-09-15 | 11:01 ET | [8-K](/filings/0001193125-25-202760.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-202760 |
| 2025-08-07 | 11:06 ET | [10-Q](/filings/0000950170-25-104550.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104550 |
| 2025-08-07 | 11:03 ET | [8-K](/filings/0000950170-25-104545.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104545 |
| 2025-06-13 | 20:02 ET | [8-K](/filings/0000950170-25-086129.md) | 5.07 Shareholder vote results | 0000950170-25-086129 |
| 2025-05-08 | 11:14 ET | [10-Q](/filings/0000950170-25-066372.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066372 |
| 2025-05-08 | 11:11 ET | [8-K](/filings/0000950170-25-066370.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-066370 |
| 2025-04-25 | 20:01 ET | [DEF 14A](/filings/0000950170-25-058686.md) | Proxy statement, period 2025-04-25 | 0000950170-25-058686 |
| 2025-03-20 | 13:04 ET | [10-K](/filings/0000950170-25-042344.md) | Annual report, period 2024-12-31 | 0000950170-25-042344 |
| 2025-03-20 | 11:03 ET | [8-K](/filings/0000950170-25-042319.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-042319 |
| 2025-01-10 | 12:03 ET | [8-K](/filings/0000950170-25-003776.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-003776 |
| 2024-12-13 | 12:03 ET | [8-K](/filings/0000950170-24-136042.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-136042 |
| 2024-12-05 | 12:03 ET | [8-K](/filings/0000950170-24-133525.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-133525 |
| 2024-11-07 | 12:07 ET | [10-Q](/filings/0000950170-24-122780.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122780 |
| 2024-11-07 | 12:02 ET | [8-K](/filings/0000950170-24-122766.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122766 |
| 2024-10-30 | 21:10 ET | [SC 13D/A](/filings/0001193125-24-247656.md) | Ownership report, active investor, amended | 0001193125-24-247656 |
| 2024-10-28 | 10:59 ET | [8-K](/filings/0000950170-24-117567.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-117567 |
| 2024-09-24 | 21:00 ET | [SC 13D/A](/filings/0001193125-24-224875.md) | Ownership report, active investor, amended | 0001193125-24-224875 |
| 2024-08-12 | 23:46 ET | [SC 13D/A](/filings/0001072613-24-000618.md) | Ownership report, active investor, amended | 0001072613-24-000618 |
| 2024-08-12 | 21:07 ET | [SC 13D/A](/filings/0001193125-24-198980.md) | Ownership report, active investor, amended | 0001193125-24-198980 |
| 2024-08-08 | 11:04 ET | [10-Q](/filings/0000950170-24-093296.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093296 |
| 2024-08-08 | 11:02 ET | [8-K](/filings/0000950170-24-093294.md) | 2.02 Results of operations | 0000950170-24-093294 |
| 2024-06-27 | 11:04 ET | [8-K](/filings/0000950170-24-078159.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-078159 |
| 2024-06-12 | 20:00 ET | [8-K](/filings/0000950170-24-072407.md) | 5.07 Shareholder vote results | 0000950170-24-072407 |
| 2024-05-30 | 11:18 ET | [8-K](/filings/0001193125-24-149802.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-149802 |
| 2024-05-16 | 20:06 ET | [8-K](/filings/0001193125-24-140533.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-140533 |
| 2024-05-13 | 00:40 ET | [SC 13D/A](/filings/0001072613-24-000471.md) | Ownership report, active investor, amended | 0001072613-24-000471 |
| 2024-05-09 | 11:45 ET | [10-Q](/filings/0000950170-24-056288.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056288 |
| 2024-05-09 | 11:05 ET | [8-K](/filings/0000950170-24-056253.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-056253 |
| 2024-05-02 | 20:03 ET | [8-K](/filings/0000950170-24-052055.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-052055 |

Page 1 of 2. [Older](/companies/glue/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.